 22 citations
,
  June 2005   in “Clinical Oncology”
           22 citations
,
  June 2005   in “Clinical Oncology”    Orlistat might block the body's ability to absorb thyroid medication.  
      2 citations
,
  June 2005   in “Clinical Oncology”
           2 citations
,
  June 2005   in “Clinical Oncology”    A man's bald spot grew hair after starting cancer treatment with gefitinib.  
      February 2020   in “Scholars academic journal of pharmacy”
           February 2020   in “Scholars academic journal of pharmacy”    The weight loss drug Orlistat can cause liver damage and should be used with caution, especially in those with liver or kidney issues.  
               4 citations
,
  January 2018   in “JBRA assisted reproduction”    Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.  
      70 citations
,
  April 2013   in “Endocrine”
           70 citations
,
  April 2013   in “Endocrine”    Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.